Targeting Complement Receptor c3ar in Neuroinflammatory CNS Disorders
Time: 10:30 am
day: Conference Day Two
Details:
- Unravelling the role of complement in neurodegenerative and psychiatric conditions
- Development of brain-penetrant small molecule inhibitors of C3aR
- Evaluating pharmacodynamic biomarkers of complement inhibition in preclinical models of neurodegeneration
